DMCC Speciality Chemicals share news and announcements

NSE: DMCCBSE: 506405Chemicals & PetrochemicalsSmall Cap

Formerly The Dharamsi Morarji Chemical Company

₹288.95₹6.85 (2.32%)BSE ₹289.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹295.80.

52-week range of traded prices to 23 Oct 2026

₹191.35Low, 30 Mar 2026₹374.15High, 6 Oct 2026

Next results date: the board meets on 30 Oct 2026 to consider: financial results.

Market cap: ₹721 Cr1,753rd largest listed
P/E: 18.0
P/B: 2.9
Dividend yield: 0.87%
ROE: 16.8%
ROCE: 19.5%
Debt to equity: 0.35
Volume, NSE: 1,45,09835.3% delivered

DMCC Speciality Chemicals board meetings

35 filed, newest first.

Oct 2026
- 22 Oct · Board meeting
  To consider and approve the financial results for the period ended September 30, 2026 (opens in a new tab)
Jul 2026
- 31 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2026 (opens in a new tab)
May 2026
- 15 May · Board meeting
  Outcome of Board Meeting held on May 15, 2026 (opens in a new tab)
- 7 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2026 and dividend (opens in a new tab)
Jan 2026
- 29 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2025 (opens in a new tab)
- 10 Jan · Board meeting
  Outcome of Board Meeting held on January 10, 2026. (opens in a new tab)
- 10 Jan · Board meeting
  Outcome of the Board meeting held on January 10, 2026. (opens in a new tab)
Nov 2025
- 3 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2025 (opens in a new tab)
Jul 2025
- 30 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2025 (opens in a new tab)
Apr 2025
- 25 Apr · Board meeting
  To consider and approve the Audited (Standalone & Consolidated) Financial Results for the period ended March 31, 2025 and recommend dividend if any subject to the approval of the shareholders at the ensuing 104th Annual General Meeting of the Company. (opens in a new tab)
Feb 2025
- 12 Feb · Board meeting
  Board meeting held on February 12, 2025 (opens in a new tab)
- 4 Feb · Board meeting
  To consider and approve the financial results for the period ended December 31, 2024 (opens in a new tab)
Oct 2024
- 28 Oct · Board meeting
  Board meeting held on October 28, 2024. (opens in a new tab)
- 16 Oct · Board meeting
  Board Meeting Intimation for inter-alia to consider and approve the financial results for the period ended September 30, 2024 (opens in a new tab)
Aug 2024
- 13 Aug · Board meeting
  Outcome of Board Meeting held on August 13, 2024. (opens in a new tab)
Jul 2024
- 26 Jul · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2024 (opens in a new tab)
May 2024
- 16 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 23, 2024, inter-alia to consider, approve and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2024 and recommendation of Final Dividend, if any, for the year ended March 31, 2024. (opens in a new tab)
Feb 2024
- 9 Feb · Board meeting
  Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ( Listing Regulations ), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on February 09, 2024 inter - alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023, along with the Unmodified Limited Review Report thereon issued by the Statutory Auditors of the Company.The Meeting of the Board of Directors commenced at 12.00 Noon (IST) and concluded at 01.20 p.m. (IST).The aforesaid results are also being made available on the Company's website at www.dmcc.com (opens in a new tab)
Jan 2024
- 31 Jan · Board meeting
  Board Meeting to be held on 09-Feb-2024 to inter-alia consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended 31st December, 2023. (opens in a new tab)
Nov 2023
- 8 Nov · Board meeting
  Board meeting held on November 08, 2023. (opens in a new tab)
- 1 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2023 (opens in a new tab)
Aug 2023
- 9 Aug · Board meeting
  Outcome of Board Meeting held on August 09, 2023. (opens in a new tab)
- 2 Aug · Board meeting
  To consider, approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30, 2023 (opens in a new tab)
May 2023
- 17 May · Board meeting
  Outcome of Board Meeting held on May 17, 2023. (opens in a new tab)
- 10 May · Board meeting
  Pursuant to the provisions of Regulation 29 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Wednesday, May 17, 2023, inter-alia to consider, approve and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2023. (opens in a new tab)
Feb 2023
- 10 Feb · Board meeting
  Board meeting held on February 10, 2023. (opens in a new tab)
Jan 2023
- 31 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2022 (opens in a new tab)
Nov 2022
- 7 Nov · Board meeting
  Dear Sir/Madam,Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ( Listing Regulations), the Board of Directors of the Company at its meeting held today i.e. 7th November, 2022, has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022, along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company. This aforesaid results are also being made available on the Company's website at www.dmcc.com The Board Meeting commenced at 12.50 p.m. (IST) and concluded at 02.55 p.m. (IST).You are requested to kindly take the same on your record. (opens in a new tab)
Oct 2022
- 31 Oct · Board meeting
  Board Meeting to be held on 07-Nov-2022 inter-alia to consider, approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2022. (opens in a new tab)
Aug 2022
- 12 Aug · Board meeting
  Board Meeting held on 12-Aug-2022 to consider financial statements for the period ended June 2022 and Other business matters (opens in a new tab)
- 5 Aug · Board meeting
  Board Meeting to be held on 12-Aug-2022 to consider financial statements for the period ended June 2022 and Other business mattersFurther, pursuant to our letter dated June 29, 2022 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till August 14, 2022 and the Trading window shall re-open on August 15, 2022.As required under SEBI (LODR) Regulation, 2015, this may be treated as an advance intimation. You are requested to kindly take the same on your record. (opens in a new tab)
May 2022
- 24 May · Board meeting
  Board Meeting held on 24-May-2022 to consider financial statements for the period ended March 2022, Dividend and Other business matters (opens in a new tab)
- 16 May · Board meeting
  Board Meeting to be held on 24-May-2022, inter-alia to consider and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the quarter and year ended March 31, 2022 and the Board may consider recommending dividend on equity shares, if any, for the financial year 2021-22. (opens in a new tab)
Feb 2022
- 11 Feb · Board meeting
  Board meeting held on February 11, 2022.Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ( Listing Regulations ), we wish to inform that: The Board of Directors of the Company at its meeting held today i.e. on 11th February, 2022 inter alia considered and approved the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and nine months ended 31st December, 2021 and we are enclosing herewith: a) Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and nine months ended 31st December, 2021;b) Limited Review Report on the Unaudited (Standalone and Consolidated) Financial Results of the Company quarter and nine months ended 31st December, 2021, issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; Further the Board of Directors has also considered redemption of 2.5%, 280000 Nos. of Non-Convertible Cumulative Preference Shares of Rs. 100/- each on or before 31st March, 2022 and the Stock Exchanges will be updated on the completion of the said redemption. The said results are also being made available on the Company's website at www.dmcc.com The Board Meeting commenced at 12:00 Noon (IST) and concluded at 2.55 p.m. (IST).You are requested to kindly take the same on your record. (opens in a new tab)
- 4 Feb · Board meeting
  Dear Sir/Madam,Pursuant to the provisions of Regulation 29 and other applicable regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, 11th February, 2022, inter-alia to consider, approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and nine months ended 31st December, 2021. Further, in continuation of our intimation dated 28th December, 2021 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company s internal code of conduct, for prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till 13th February, 2022 and the Trading window shall re-open on 14th February, 2022.As required under SEBI (LODR) Regulation, 2015, this may be treated as an advance intimation. You are requested to kindly take the same on your record. (opens in a new tab)

DMCC Speciality Chemicals board meetings

Oct 2026

Jul 2026

May 2026

Jan 2026

Nov 2025

Jul 2025

Apr 2025

Feb 2025

Oct 2024

Aug 2024

Jul 2024

May 2024

Feb 2024

Jan 2024

Nov 2023

Aug 2023

May 2023

Feb 2023

Jan 2023

Nov 2022

Oct 2022

Aug 2022

May 2022

Feb 2022